Experimental procedures are treatments or services a health plan considers investigational, unproven, or not medically established enough for routine coverage. In plain language, they are procedures the insurer does not view as standard covered care under the policy’s evidence and medical-necessity rules.
Why plans deny them
Health plans usually do not deny these claims just because the treatment is new. They deny them because the policy language and clinical review process may conclude that the treatment:
- lacks sufficient evidence of safety or effectiveness
- is still under study
- is not accepted as standard treatment for the condition
- does not meet the plan’s definition of medical necessity
Two plans can treat the same procedure differently if their policy wording, clinical criteria, or appeals rules differ.
Claims and appeal mechanics
When a procedure is denied as experimental or investigational, the insured may need to review:
- the exact denial reason
- whether prior authorization was requested
- whether the plan’s medical policy was applied correctly
- internal appeal and external review rights
Disputes often turn on evidence, coding, and whether the requested treatment is considered standard of care for that diagnosis.
Practical example
A member seeks coverage for a new therapy available only in limited specialized centers. The plan denies it as investigational because its medical policy says long-term clinical outcomes are not established yet. The member may then appeal with physician letters and published evidence supporting the treatment.